← all works
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- The Lancet Oncology
- Topic
- Head and Neck Cancer Studies
- Field
- Medicine
- Canadian institutions
- McMaster UniversityHamilton Regional Laboratory Medicine Program
- Funders
- —
- Keywords
- MedicineCetuximabHead and neck cancerClinical endpointRadiation therapyRashInternal medicineOncologyHead and neck squamous-cell carcinomaRandomized controlled trialSurgeryCancerColorectal cancer
- Has abstract in OpenAlex
- no